Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC

Clinical trial NCT06663137 · RECRUITING

Trial details

NCT number: NCT06663137
Sponsor: Relmada Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Muscle Invasive Bladder Cancer

Start date: 2024-08-01
Primary completion: 2025-08-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.